Product Images Venlafaxine Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Venlafaxine Hydrochloride NDC 70518-4154 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Remedy_Label - Remedy Label
This is information about Venlafaxine, an extended-release medication in the dose of 150 mg. The medication comes in a capsule form with a quantity of 30 capsules. The manufacturer is Epic Pharma, LLC, located in Laurelton, NY. The directions for use are mentioned to refer to the package insert. It should be stored at temperatures between 20-25°C (58-77°F) with excursions permitted to 15.30°C (59-86°F). The medication should be kept out of the reach of children. Additionally, it was repackaged by RemedyRepack Inc. in Indiana, PA.*
image-01 - image 01
image-02 - image 02
This text includes information related to special healthcare considerations for hepatic and renal impairment, as well as specific considerations for aging populations, gender differences, and genetic variability affecting drug metabolism. The document also mentions variations in analyte levels and fold change data, indicating potential impacts on pharmacokinetics. These details can be valuable in understanding drug effects and dosing adjustments in various patient populations.*
image-03 - image 03
This is a list of drug-drug interactions showing the fold change and 90% confidence interval for various drug analytes when interacting with venlafaxine and other medications such as ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The text also includes information on interactions based on different CYP2D6 phenotypes. The data seems to compare the maximum concentration (Cmax) and area under the curve (AUC) for these drug combinations. This information can be useful in understanding how these medications may influence each other's pharmacokinetics.*
image-04 - image 04
This appears to be a list of interacting drugs, analytes, and active moieties along with fold change and 90% confidence intervals. The drugs include Ethanor, Diazepam, Alprazolam, Indinavic, Metoprolol, Risperidone, Imipramine, Haloperidol, Caffeine, Tolbutamide, and Lithium. The text mentions various derivatives and metabolites of these drugs as well. Additionally, it outlines the fold change relative to a reference value for each drug.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
